Health evidence
Clinical studies, with limits made explicit
Human studies of dissolved molecular hydrogen exist, but many are small, open-label, short, or condition-specific. They are not evidence that unrelated magnetic or vortex products create durable beneficial “structure.”
A product-specific safety record
FDA and CDC records document an acute nonviral hepatitis investigation tied to the named Real Water alkaline-water product. CDC explicitly reported that the evidence did not indicate involvement of other brands. The record is important, but it is not a basis for treating every alkaline, hydrogen-rich, electrolyzed, or “structured” water product as equivalent.
Hydrogen-rich water trials
Open-label pilots in rheumatoid arthritis and myopathies, radiotherapy quality-of-life studies, athlete fatigue trials, and controlled trials in healthy adults and swimmers.
Metabolic and liver markers
Some studies report changes in selected biomarkers; others report null primary comparisons or modest effects. Systematic reviews continue to call for larger, more rigorous trials.
Clinical evidence guardrails
- We list trial design details to distinguish exploratory from confirmatory evidence.
- Outcomes are reported as in the paper, without extrapolation to unrelated claims.
- A biomarker change is not automatically a patient-important clinical benefit.
- Safety and regulatory records are included separately from efficacy evidence.
This archive is not medical advice and does not recommend using any water product to diagnose, treat, or replace care for a health condition.